Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Class A Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
65.3M
-
Number of holders
-
71
-
Total shares
-
45.7M
-
Shares change
-
+2.82M
-
Total reported value, excl. options
-
$58.9M
-
Value change
-
+$1.9M
-
Put/Call ratio
-
60
-
Number of buys
-
27
-
Number of sells
-
-39
-
Price
-
$1.29
Significant Holders of Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) as of Q1 2025
96 filings reported holding ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share as of Q1 2025.
Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.7M shares
of 65.3M outstanding shares and own 69.95% of the company stock.
Largest 10 shareholders include VR ADVISER, LLC (5.02M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (4.86M shares), Deep Track Capital, LP (3.28M shares), RA CAPITAL MANAGEMENT, L.P. (3.22M shares), GREAT POINT PARTNERS LLC (3.17M shares), Pfizer Inc (2.97M shares), ADAR1 Capital Management, LLC (2.8M shares), BlackRock, Inc. (2.72M shares), JPMORGAN CHASE & CO (2.61M shares), and BRAIDWELL LP (2.47M shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.